Revolutionizing health
one microbiome at a time
WHO WE ARE
Lunken Lab focuses on expanding our knowledge of host-immune-microbe interactions, with a specific focus on identifying host (i.e., diet) and microbial factors involved in different responses to medical and dietary therapies.
By better understanding individualized response to treatments, we can move towards developing and using personalized therapeutic programs to improve patient outcomes. We use various digital health technologies and ‘multi-omics’ techniques (i.e., metagenomics, metabolomics, metaproteomics) to explore the role that dietary intakes and the microbes residing in the gastrointestinal tract play in changing the response to therapy.
Research theme
Lunken Lab’s primary research focus revolves around investigating the nuanced interplay between nutritional and medical interventions in individuals with inflammatory bowel disease.
Specifically, our research places a significant emphasis on understanding the role of fungi in this context. Our research aims to deepen our comprehension of existing therapies and pinpoint opportunities for improvement. An example of our ongoing efforts is the OPTIMIST clinical study, which investigates the detection of biomarkers in the gut microbiome to enhance our ability to predict treatment outcomes in patients with Crohn’s disease.
latest Posts
Follow Along with us
@GenelleLunken
Affiliated With
